Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9274200 | 0.85 | THRB (0.44) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL2307504 | 0.85 | THRB (0.44) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL7536676 | 0.85 | THRB (0.44) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL1615681 | 0.79 | NAAA (0.40) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL1337900 | 0.78 | NPSR1 (0.42) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL27533433 | 0.78 | THRB (0.55) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL9274202 | 0.78 | THRB (0.55) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL9274205 | 0.78 | THRB (0.55) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL1337905 | 0.78 | NPSR1 (0.42) | NAAANPSR1CYP19A1THRBCYP2C9 | |
| SCHEMBL4451204 | 0.76 | THRB (0.36) | NAAANPSR1CYP19A1THRBCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328987-B1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | Henkel IP & Holding GmbH (DE) | 2018-02-21 | — | — | EP | claimed |
| CN-102369252-B | Transferable curable non-liquid films on release substrates | LOCTITE R & D LTD | 2015-03-11 | — | — | CN | claimed |
| US-8425999-B2 | Transferable curable non-liquid film on a release substrate | HENKEL IRELAND LIMITED (DE) | 2013-04-23 | — | — | US | claimed |
| CN-102369252-A | Transferable curable non-liquid films on release substrates | LOCTITE R & D LTD | 2012-03-07 | — | — | CN | claimed |
| US-20110151243-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | LOCTITE (R&D) LIMITED (IE) | 2011-06-23 | — | — | US | claimed |
| EP-2328987-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | Loctite (R & D) Limited (IE) | 2011-06-08 | — | — | EP | claimed |
| WO-2010023229-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | LOCTITE (R&D) LIMITED (IE) | 2010-03-04 | — | — | WO | claimed |
| US-20260115350-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CHEMENCE MEDICAL, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260034263-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CHEMENCE MEDICAL, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4608462-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | Chemence Medical, Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4608461-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | Chemence Medical, Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024092049-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CHEMENCE MEDICAL, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2024092036-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CHEMENCE MEDICAL, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2014131650-A1 | HOT MELT ADHESIVE COMPRISING CYANOACRYLATE CURING COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2014-09-04 | — | — | WO | disclosed |
| US-20140238603-A1 | HOT MELT ADHESIVE COMPRISING CYANOACRYLATE CURING COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2014-08-28 | — | — | US | disclosed |
| US-8425999-B2 | Transferable curable non-liquid film on a release substrate | HENKEL IRELAND LIMITED (DE) | 2013-04-23 | — | — | US | disclosed |
| CN-102369252-A | Transferable curable non-liquid films on release substrates | LOCTITE R & D LTD | 2012-03-07 | — | — | CN | disclosed |
| US-20110151243-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | LOCTITE (R&D) LIMITED (IE) | 2011-06-23 | — | — | US | disclosed |
| EP-2328987-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | Loctite (R & D) Limited (IE) | 2011-06-08 | — | — | EP | disclosed |
| WO-2010023229-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | LOCTITE (R&D) LIMITED (IE) | 2010-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115350-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CUTA, ICAM1, CLSPN | NAAA 2186/4885NPSR1 3567/4885CYP19A1 2059/4885 |
| US-20260034263-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CUTA, ICAM1, CLSPN | NAAA 2433/4885NPSR1 3403/4885CYP19A1 1767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.